SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is trending following recent showcases of its advanced agentic and voice AI solutions at a major tech conference, drawing significant community discussion around new partnerships in automotive and robotics. Investors are also actively debating the company's unique technology, which emphasizes client data privacy, and its substantial short interest.

Atara Biotherapeutics, Inc. is an allogeneic T-cell immunotherapy company, which engages in the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases. It also delivers off-the-shelf treatments to patients with high unmet medical need. Its product pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in Thousand Oaks, CA.

Atara Biotherapeutics Inc

Atara Biotherapeutics (ATRA) is trending following a second FDA Complete Response Letter for its EBVALLO cancer therapy, which now cites concerns over clinical trial design despite previously resolved manufacturing issues. The community is expressing significant frustration over the FDA's unexpected change in position and questioning the need for a new trial, especially given the drug's existing approval in Europe.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Tempus AI Inc

Tempus AI is trending following strong preliminary financial results, which exceeded revenue expectations and highlighted record total contract value with high net revenue retention. This news, driven by significant growth in its diagnostics segment, is fueling community discussion around the company's strategic position in AI-powered oncology and precision medicine. Investors are actively debating the sustainability of its growth trajectory and valuation after substantial recent share appreciation.

Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. It offers commercial and development products of anti-viral compounds and human vaccines. The commercialized products include vaccines for typhoid fever, meningococcus, and leptospirosis. The products under development include vaccines for chronic hepatitis B, ebola, and dengue virus. The company was founded by Philippe Pouletty on December 4, 2003 and is headquartered in Paris, France.

Abivax - ADR

Abivax (ABVX) is trending due to heightened speculation surrounding a potential takeover by Eli Lilly and other major pharmaceutical companies, with reports from French media and government sources fueling the buzz. The community is actively discussing an impending bidding war and significant premiums for its promising ulcerative colitis drug, obefazimod, which has demonstrated strong Phase 3 data. This innovative treatment positions Abivax as a highly attractive target in the competitive inflammatory bowel disease market.

Walmart, Inc. engages in the retail and wholesale business. The company offers an assortment of merchandise and services at everyday low prices. It operates through the following business segments: Walmart U.S., Walmart International, and Sam's Club. The Walmart U.S. segment operates as a mass merchandiser of consumer products, operating under the Walmart and Walmart Neighborhood Market brands, including walmart.com. The Walmart International segment includes operations of wholly-owned subsidiaries in Canada, Chile, China, and Africa, and majority-owned subsidiaries in India, as well as Mexico and Central America. The Sam's Club segment manages membership-only warehouse clubs and operates samsclub.com. The company was founded by Samuel Moore Walton and James Lawrence Walton on July 2, 1962 and is headquartered in Bentonville, AR.

Walmart Inc

Walmart is trending due to its ongoing transformation into a technology-driven e-commerce giant, prominently featuring new AI partnerships with Google's Gemini and an expansion of drone delivery services. Community discussions highlight its upcoming inclusion in the Nasdaq-100, affirming its strategic shift, while also debating whether its valuation aligns with these evolving retail fundamentals.

Biodesix, Inc. provides blood-based diagnostics services for patients with lung disease. The firm offers GeneStrat, a genomic blood test for patients who have been diagnosed with advanced lung cancer and VeriStrat, a serum proteomic test that provides prognostic and predictive information for patients with non-small cell lung cancer. It also offers six diagnostic tests including: Nodify XL2, Nodify CDT, GeneStrat, VeriStrat, Bio-Rad SARS-CoV-2 ddPCR test and the Platelia SARS-CoV-2 test. The company was founded by David Brunel and Robert E. Cawthorn in 2005 and is headquartered in Louisville, CO.

Biodesix Inc

Biodesix (BDSX) is trending after announcing preliminary quarterly and full-year results that significantly beat revenue expectations, sparking strong bullish sentiment across the community. Investors are keenly discussing the impressive growth, coupled with high analyst price targets and the potential for a rally driven by the stock's low free float. However, some continue to voice concerns regarding the company's cash reserves and the ongoing risk of dilution.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is trending lower amid a Bank of America downgrade citing over-optimistic forward estimates and heightened competitive concerns as Amazon Pharmacy now offers Novo Nordisk's popular weight-loss pill, which is notably absent from HIMS's platform. This is fueling a heated debate, with many viewing the dip as a long-term buying opportunity given HIMS's personalized healthcare and vertical integration strategy, while others anticipate further declines due to competitive pressures and regulatory scrutiny.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals is trending as the community reacts to the anticipated FDA approval of ORLADEYO oral pellets for pediatric hereditary angioedema patients, a positive development met with frustration over the stock's lack of upward movement. Investors are actively debating the company's recent conservative 2026 revenue guidance, despite a 9% wholesale acquisition cost increase and growing revenue for its flagship HAE treatment. The sentiment is further shaped by the recent CEO transition, with many hoping new leadership will address the stock's perceived undervaluation amid ongoing market manipulation claims.

Abercrombie & Fitch Co. engages in the retail of apparel, personal care products, and accessories. The firm operates through following geographical segments: Americas, EMEA and APAC. The Americas segment includes operations in North America and South America. The EMEA segment includes operations in Europe, the Middle East and Africa. The APAC segment includes operations in the Asia-Pacific region, including Asia and Oceania. The company was founded by David Abercrombie in 1892 and is headquartered in New Albany, OH.

Abercrombie & Fitch Co. - Ordinary Shares - Class A

Abercrombie & Fitch Co.

Abercrombie & Fitch is experiencing significant trending activity following a strong earnings report that propelled its share price upward, fueling speculation of a short squeeze. However, this momentum has met with strong opposing views and a sharp pullback, as recent indications of disappointing holiday sales and a tempered forward outlook trigger investor apprehension regarding its sustained valuation.

Nuvation Bio, Inc. is a biopharmaceutical company tackling some of the unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. The company was founded by David Hung on March 20, 2018 and is headquartered in New York, NY.

Nuvation Bio Inc - Ordinary Shares - Class A

Nuvation Bio is trending following a significant strategic collaboration for global expansion of its lead oncology therapy. The community is buzzing about the strong commercial performance and impressive clinical data for its core assets, solidifying a "best-in-class" perception and fueling acquisition speculation within an active biotech market.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

🐉 $PTON CALL — DragonAlgo® VIP Signal

Contract: PTON 2026-01-16 C2
Expiry: 2026-01-16 | Strike: 2.00 | Type: CALL

Option Plan (premium):
Entry: 4.80
Stop: 3.46
TP1: 6.24
TP2: 8.16
TP3: 11.52

TA:

Educational only — not financial advice.

🔗 https://dragonalgo.com

Dragonalgo

Hostinger Horizons

StockTwits Web

Peloton Interactive Inc

 CALL — DragonAlgo® VIP Signal

Contract: PTON 2026-01-16 C2
Expiry: 2026-01-16 | Strike: 2.00 | Type: CALL

Option Plan (premium):
Entry: 4.80
Stop: 3.46
TP1: 6.24
TP2: 8.16
TP3: 11.52

TA:

Educational only — not financial advice.

🔗 